US Stock MarketDetailed Quotes

Argent Biopharma (RGTLF)

Watchlist
  • 0.0303
  • +0.0023+8.21%
15min DelayClose May 22 15:34 ET
3.37MMarket Cap-0.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Argent Biopharma (RGTLF) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities
249.03%208.83K
-370.77%-140.12K
102.12%51.75K
-158.06%-2.44M
2.38%-946.78K
-2.41%-969.88K
-178.07%-947.04K
46.05%-340.58K
3.03%-631.23K
-105.74%-650.94K
Capital expenditure reported
----
----
----
----
----
----
----
----
413.67%500K
49.62%-159.4K
Net PPE purchase and sale
249.03%208.83K
81.03%-140.12K
81.62%-738.67K
-358.47%-4.02M
8.39%-876.36K
-153.72%-956.63K
-10.71%-377.04K
69.90%-340.58K
-1,178.12%-1.13M
---88.52K
Net intangibles purchase and sale
----
----
----
--151.43K
----
----
----
----
----
---33.42K
Net business purchase and sale
----
----
----
98.78%-4.55K
-2,716.55%-373.25K
98.84%-13.25K
---1.14M
----
-99.91%124
--142.57K
Net investment purchase and sale
----
----
----
-151.51%-155.97K
--302.82K
----
----
----
----
----
Net other investing changes
----
----
-49.95%790.42K
-17.05%1.58M
--1.9M
----
----
----
197.62%500K
---512.17K
Cash from discontinued investing activities
Investing cash flow
249.03%208.83K
-370.77%-140.12K
102.12%51.75K
-158.06%-2.44M
2.38%-946.78K
-2.41%-969.88K
-178.07%-947.04K
46.05%-340.58K
3.03%-631.23K
-105.74%-650.94K
Financing cash flow
Cash flow from continuing financing activities
-36.82%9.39M
59.65%14.87M
-4.36%9.31M
-41.63%9.74M
56.67%16.68M
39,307.40%10.65M
-99.43%27.01K
-46.64%4.7M
-22.26%8.81M
1,359.40%11.33M
Net issuance payments of debt
---200K
----
11,759.18%7.28M
-98.93%61.42K
--5.75M
----
----
----
-224.22%-1M
--805K
Net common stock issuance
-31.15%10.4M
477.16%15.1M
-73.83%2.62M
-13.49%10M
8.56%11.56M
39,307.40%10.65M
-99.43%27.01K
-52.08%4.7M
-6.82%9.81M
1,255.73%10.53M
Net other financing activities
-69.01%-806.78K
16.97%-477.36K
-9.30%-574.92K
40.57%-526.02K
8.87%-885.1K
---971.29K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-36.82%9.39M
59.65%14.87M
-4.36%9.31M
-41.63%9.74M
56.67%16.68M
39,307.40%10.65M
-99.43%27.01K
-46.64%4.7M
-22.26%8.81M
1,359.40%11.33M
Net cash flow
Beginning cash position
193.08%702.87K
-87.29%239.82K
-65.28%1.89M
190.02%5.43M
-20.42%1.87M
-76.12%2.35M
-13.24%9.86M
43.93%11.36M
1,706.82%7.9M
-26.57%436.99K
Current changes in cash
-30.66%321.54K
140.04%463.71K
67.27%-1.16M
-207.29%-3.54M
809.36%3.3M
93.61%-464.85K
-376.42%-7.27M
-143.34%-1.53M
-52.79%3.52M
4,836.29%7.46M
Effect of exchange rate changes
99.54%-3
99.87%-658
-284.93%-488.46K
-148.36%-126.9K
1,753.85%262.42K
93.12%-15.87K
-1,152.14%-230.66K
140.34%21.92K
-1,654.60%-54.34K
-452.05%-3.1K
End cash Position
45.75%1.02M
193.08%702.87K
-86.44%239.82K
-67.45%1.77M
190.02%5.43M
-20.42%1.87M
-76.12%2.35M
-13.24%9.86M
43.93%11.36M
1,706.82%7.9M
Free cash flow
35.55%-9.28M
-27.91%-14.4M
24.17%-11.26M
5.79%-14.85M
-41.96%-15.76M
-65.31%-11.1M
-5.83%-6.72M
-20.03%-6.35M
-50.98%-5.29M
-274.89%-3.5M
Currency Unit
AUD
AUD
AUD
AUD
AUD
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities 249.03%208.83K-370.77%-140.12K102.12%51.75K-158.06%-2.44M2.38%-946.78K-2.41%-969.88K-178.07%-947.04K46.05%-340.58K3.03%-631.23K-105.74%-650.94K
Capital expenditure reported --------------------------------413.67%500K49.62%-159.4K
Net PPE purchase and sale 249.03%208.83K81.03%-140.12K81.62%-738.67K-358.47%-4.02M8.39%-876.36K-153.72%-956.63K-10.71%-377.04K69.90%-340.58K-1,178.12%-1.13M---88.52K
Net intangibles purchase and sale --------------151.43K-----------------------33.42K
Net business purchase and sale ------------98.78%-4.55K-2,716.55%-373.25K98.84%-13.25K---1.14M-----99.91%124--142.57K
Net investment purchase and sale -------------151.51%-155.97K--302.82K--------------------
Net other investing changes ---------49.95%790.42K-17.05%1.58M--1.9M------------197.62%500K---512.17K
Cash from discontinued investing activities
Investing cash flow 249.03%208.83K-370.77%-140.12K102.12%51.75K-158.06%-2.44M2.38%-946.78K-2.41%-969.88K-178.07%-947.04K46.05%-340.58K3.03%-631.23K-105.74%-650.94K
Financing cash flow
Cash flow from continuing financing activities -36.82%9.39M59.65%14.87M-4.36%9.31M-41.63%9.74M56.67%16.68M39,307.40%10.65M-99.43%27.01K-46.64%4.7M-22.26%8.81M1,359.40%11.33M
Net issuance payments of debt ---200K----11,759.18%7.28M-98.93%61.42K--5.75M-------------224.22%-1M--805K
Net common stock issuance -31.15%10.4M477.16%15.1M-73.83%2.62M-13.49%10M8.56%11.56M39,307.40%10.65M-99.43%27.01K-52.08%4.7M-6.82%9.81M1,255.73%10.53M
Net other financing activities -69.01%-806.78K16.97%-477.36K-9.30%-574.92K40.57%-526.02K8.87%-885.1K---971.29K----------------
Cash from discontinued financing activities
Financing cash flow -36.82%9.39M59.65%14.87M-4.36%9.31M-41.63%9.74M56.67%16.68M39,307.40%10.65M-99.43%27.01K-46.64%4.7M-22.26%8.81M1,359.40%11.33M
Net cash flow
Beginning cash position 193.08%702.87K-87.29%239.82K-65.28%1.89M190.02%5.43M-20.42%1.87M-76.12%2.35M-13.24%9.86M43.93%11.36M1,706.82%7.9M-26.57%436.99K
Current changes in cash -30.66%321.54K140.04%463.71K67.27%-1.16M-207.29%-3.54M809.36%3.3M93.61%-464.85K-376.42%-7.27M-143.34%-1.53M-52.79%3.52M4,836.29%7.46M
Effect of exchange rate changes 99.54%-399.87%-658-284.93%-488.46K-148.36%-126.9K1,753.85%262.42K93.12%-15.87K-1,152.14%-230.66K140.34%21.92K-1,654.60%-54.34K-452.05%-3.1K
End cash Position 45.75%1.02M193.08%702.87K-86.44%239.82K-67.45%1.77M190.02%5.43M-20.42%1.87M-76.12%2.35M-13.24%9.86M43.93%11.36M1,706.82%7.9M
Free cash flow 35.55%-9.28M-27.91%-14.4M24.17%-11.26M5.79%-14.85M-41.96%-15.76M-65.31%-11.1M-5.83%-6.72M-20.03%-6.35M-50.98%-5.29M-274.89%-3.5M
Currency Unit AUDAUDAUDAUDAUDAUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.09%
Sample Name
Sample Code
 +8.38%
Sample Name
Sample Code
 +7.98%
4
United States Oil Fund LP
USO
+6.44%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+5.55%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +7.60%
Sample Name
Sample Code
 +7.37%
Sample Name
Sample Code
 +6.61%
4
United Microelectronics
UMC
+5.93%
5
Tencent Music
TME
+4.01%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -